PT Medikaloka Hermina Tbk (HEAL.JK)

IDR 1045.0

(0.97%)

Operating Income Summary of PT Medikaloka Hermina Tbk

PT Medikaloka Hermina Tbk's latest annual operating income in 2023 was 780.69 Billion IDR , up 32.91% from previous year.
PT Medikaloka Hermina Tbk's latest quarterly operating income in 2024 Q3 was 250.12 Billion IDR , down -10.86% from previous quarter.
PT Medikaloka Hermina Tbk reported an annual operating income of 587.37 Billion IDR in 2022, down -66.97% from previous year.
PT Medikaloka Hermina Tbk reported an annual operating income of 1778.16 Billion IDR in 2021, up 70.66% from previous year.
PT Medikaloka Hermina Tbk reported a quarterly operating income of 280.6 Billion IDR for 2024 Q2, down -15.26% from previous quarter.
PT Medikaloka Hermina Tbk reported a quarterly operating income of 331.15 Billion IDR for 2024 Q1, up 102.22% from previous quarter.

Annual Operating Income Chart of PT Medikaloka Hermina Tbk (2023 - 2015)

Historical Annual Operating Income of PT Medikaloka Hermina Tbk (2023 - 2015)

Year	Operating Income	Operating Income Growth
2023	780.69 Billion IDR	32.91%
2022	587.37 Billion IDR	-66.97%
2021	1778.16 Billion IDR	70.66%
2020	1041.93 Billion IDR	78.62%
2019	583.33 Billion IDR	51.13%
2018	385.97 Billion IDR	0.11%
2017	385.56 Billion IDR	12.29%
2016	343.35 Billion IDR	61.4%
2015	212.73 Billion IDR	0.0%

Year	Operating Income	Operating Income Growth
2024 Q3	250.12 Billion IDR	-10.86%
2024 Q2	280.6 Billion IDR	-15.26%
2024 Q1	331.15 Billion IDR	102.22%
2023 Q3	270.3 Billion IDR	57.67%
2023 Q2	171.44 Billion IDR	-13.23%
2023 Q1	197.59 Billion IDR	97.37%
2023 FY	780.69 Billion IDR	32.91%
2023 Q4	163.75 Billion IDR	-39.42%
2022 Q1	212.17 Billion IDR	-40.77%
2022 FY	587.37 Billion IDR	-66.97%
2022 Q4	100.11 Billion IDR	-33.77%
2022 Q3	151.17 Billion IDR	22.0%
2022 Q2	123.9 Billion IDR	-41.6%
2021 Q3	405.19 Billion IDR	-16.73%
2021 Q1	528.12 Billion IDR	7.32%
2021 Q2	486.63 Billion IDR	-7.86%
2021 FY	1778.16 Billion IDR	70.66%
2021 Q4	358.2 Billion IDR	-11.6%
2020 Q4	492.08 Billion IDR	56.84%
2020 Q2	66.95 Billion IDR	-60.42%
2020 Q3	313.74 Billion IDR	368.63%
2020 Q1	169.15 Billion IDR	31.35%
2020 FY	1041.93 Billion IDR	78.62%
2019 Q3	168.79 Billion IDR	14.84%
2019 Q1	138.77 Billion IDR	70.4%
2019 FY	583.33 Billion IDR	51.13%
2019 Q4	128.78 Billion IDR	-23.7%
2019 Q2	146.98 Billion IDR	5.91%
2018 Q1	106.42 Billion IDR	10.83%
2018 FY	385.97 Billion IDR	0.11%
2018 Q4	81.44 Billion IDR	-13.58%
2018 Q3	94.23 Billion IDR	-9.27%
2018 Q2	103.87 Billion IDR	-2.4%
2017 Q2	98.57 Billion IDR	0.0%
2017 Q1	98.57 Billion IDR	0.0%
2017 Q3	92.98 Billion IDR	-5.67%
2017 Q4	96.02 Billion IDR	3.27%
2017 FY	385.56 Billion IDR	12.29%
2016 FY	343.35 Billion IDR	61.4%
2015 FY	212.73 Billion IDR	0.0%

Peer Operating Income Comparison of PT Medikaloka Hermina Tbk

Name	Operating Income	Operating Income Difference
PT Bundamedik Tbk	211.43 Billion IDR	-269.232%
PT Metro Healthcare Indonesia Tbk	-36.13 Billion IDR	2260.28%
PT Mitra Keluarga Karyasehat Tbk	1207.01 Billion IDR	35.32%
PT Murni Sadar Tbk	15.2 Billion IDR	-5034.14%
PT Famon Awal Bros Sedaya Tbk	204.41 Billion IDR	-281.911%
PT Royal Prima Tbk	-4.62 Billion IDR	16990.745%
PT Kedoya Adyaraya Tbk	29.49 Billion IDR	-2546.672%
PT Sarana Meditama Metropolitan Tbk	47.32 Billion IDR	-1549.59%
PT Siloam International Hospitals Tbk	1728.28 Billion IDR	54.828%
PT Sejahteraraya Anugrahjaya Tbk	106.26 Billion IDR	-634.699%